5,0
18 gen 2025
Dipendente attuale, più di 8 anni
Rahway, NJ
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Transparent leadership with a focus on patients and science.
Svantaggi
Immediate sales are based on blockbuster drug set to lose patent exclusivity.